Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis–update 2015. J Hepatol. 2015;62(1 Suppl):S100–11.
Article
PubMed
Google Scholar
Czaja AJ. Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol. 2013;7(4):365–85.
Article
PubMed
CAS
Google Scholar
Yang F, Wang Q, Bian Z, Ren LL, Jia J, Ma X. Autoimmune hepatitis: east meets west. J Gastroenterol Hepatol. 2015;30(8):1230–6.
Article
PubMed
Google Scholar
Wang QX, Yan L, Ma X. Autoimmune hepatitis in the Asia-Pacific Area. J Clin Transl Hepatol. 2018;6(1):48–56.
Article
PubMed
Google Scholar
Sahebjam F, Vierling JM. Autoimmune hepatitis. Front Med. 2015;9(2):187–219.
Article
PubMed
Google Scholar
Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM. Diagnosis and management of autoimmune hepatitis. Hepatology. 2010;51(6):2193–213.
Article
PubMed
CAS
Google Scholar
EASL Clinical Practice Guidelines. Autoimmune hepatitis. J Hepatol. 2015;63(4):971–1004.
Article
Google Scholar
Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. AM J Gastroenterol. 2002;97(10):2614–8.
Article
PubMed
Google Scholar
Mehta SH, Lau B, Afdhal NH, Thomas DL. Exceeding the limits of liver histology markers. J Hepatol. 2009;50(1):36–41.
Article
PubMed
Google Scholar
Kim WR, Berg T, Asselah T, Flisiak R, Fung S, Gordon SC, Janssen HL, Lampertico P, Lau D, Bornstein JD, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64(4):773–80.
Article
PubMed
CAS
Google Scholar
Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32–6.
Article
PubMed
CAS
Google Scholar
Castera L. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: non-invasive tests are enough. Liver int. 2018;38(Suppl 1):67–70.
Article
PubMed
Google Scholar
Herrmann E, de Ledinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260–72.
Article
PubMed
CAS
Google Scholar
Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M, Hubener S, Pannicke N, Weiler-Normann C, Quaas A, et al. Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis. J Hepatol. 2016;65(4):769–75.
Article
PubMed
Google Scholar
Datz C, Felder TK, Niederseer D, Aigner E. Iron homeostasis in the metabolic syndrome. Eur J Clin Invest. 2013;43(2):215–24.
Article
PubMed
CAS
Google Scholar
Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis. 2005;25(4):461–72.
Article
PubMed
CAS
Google Scholar
Hearnshaw S, Thompson NP, McGill A. The epidemiology of hyperferritinaemia. World J Gastroenterol. 2006;12(36):5866–9.
Article
PubMed
PubMed Central
Google Scholar
Camaschella C, Poggiali E. Towards explaining “unexplained hyperferritinemia.” Haematologica. 2009;94(3):307–9.
Article
PubMed
PubMed Central
Google Scholar
Fargion S, Valenti L, Fracanzani AL. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases. Dig Liver Dis. 2011;43(2):89–95.
Article
PubMed
Google Scholar
Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther. 2012;35(8):876–93.
Article
PubMed
CAS
Google Scholar
Taubert R, Hardtke-Wolenski M, Noyan F, Lalanne C, Jonigk D, Schlue J, Krech T, Lichtinghagen R, Falk CS, Schlaphoff V, et al. Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis. PLoS ONE. 2017;12(6):e179074.
Article
Google Scholar
An IC, Tiwari AK, Ameda S, Laird-Fick HS. Autoimmune hepatitis: diagnostic dilemma in the setting of suspected iron overload. Case Rep Gastrointest Med. 2013;2013:872987.
PubMed
PubMed Central
Google Scholar
Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, Dufour JF, Gerlach TJ, Heim MH, Malinverni R, et al. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology. 2012;55(4):1038–47.
Article
PubMed
CAS
Google Scholar
Batsaikhan B, Gantumur G, Huang CI, Yeh ML, Huang CF, Lin ZY, Chen SC, Huang JF, Yu ML, Chuang WL, et al. Elevated serum ferritin level associated with hepatic steatosis and fibrosis in hepatitis C virus-infected patients. J Chin Med Assoc. 2019;82(2):99–104.
Article
PubMed
Google Scholar
Manousou P, Kalambokis G, Grillo F, Watkins J, Xirouchakis E, Pleguezuelo M, Leandro G, Arvaniti V, Germani G, Patch D, et al. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int. 2011;31(5):730–9.
Article
PubMed
CAS
Google Scholar
Kowdley KV, Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(1):77–85.
Article
PubMed
CAS
Google Scholar
Jung JY, Shim JJ, Park SK, Ryoo JH, Choi JM, Oh IH, Jung KW, Cho H, Ki M, Won YJ, et al. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population. Hepatol Int. 2019;13(2):222–33.
Article
PubMed
Google Scholar
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WG, Czaja AJ, Desmet VJ, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31(5):929–38.
Article
PubMed
CAS
Google Scholar
Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48(1):169–76.
Article
PubMed
Google Scholar
Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47(4):598–607.
Article
PubMed
Google Scholar
Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol. 1995;19(12):1409–17.
Article
PubMed
CAS
Google Scholar
Mieli-Vergani G, Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol. 2011;8(6):320–9.
Article
PubMed
CAS
Google Scholar
Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev. 2006;27(1):5–16.
PubMed
PubMed Central
Google Scholar
Milto IV, Suhodolo IV, Prokopieva VD, Klimenteva TK. Molecular and cellular bases of iron metabolism in humans. Biochemistry. 2016;81(6):549–64.
PubMed
CAS
Google Scholar
Vulpe CD, Kuo YM, Murphy TL, Cowley L, Askwith C, Libina N, Gitschier J, Anderson GJ. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999;21(2):195–9.
Article
PubMed
CAS
Google Scholar
Adams PC, Barton JC. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. J Hepatol. 2011;55(2):453–8.
Article
PubMed
CAS
Google Scholar
Fairbanks VF. Laboratory testing for iron status. Hosp Pract. 1991;26(Suppl 3):17–24.
Article
Google Scholar
Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta. 2012;1820(3):188–202.
Article
PubMed
CAS
Google Scholar
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275(3):161–203.
Article
PubMed
Google Scholar
Bhagat CI, Fletcher S, Joseph J, Beilby JP. Plasma ferritin in acute hepatocellular damage. Clin Chem. 2000;46(6 Pt 1):885–6.
Article
PubMed
CAS
Google Scholar
Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal. 1998;12(6):363–70.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bruns T, Nuraldeen R, Mai M, Stengel S, Zimmermann HW, Yagmur E, Trautwein C, Stallmach A, Strnad P. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis. Liver Int. 2017;37(2):232–41.
Article
PubMed
CAS
Google Scholar
Ribot-Hernandez I, Martin-Gonzalez C, Vera-Delgado V, Gonzalez-Navarrete L, de Armas-Gonzalez JF, Vina-Rodriguez J, Sanchez-Perez MJ, Rodriguez-Gaspar M, Gonzalez-Reimers E. Prognostic value of serum iron, ferritin, and transferrin in chronic alcoholic liver disease. Biol Trace Elem Res. 2020;195(2):427–35.
Article
PubMed
CAS
Google Scholar
Sebastiani G, Tempesta D, Alberti A. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. J Viral Hepat. 2012;19(2):e170–6.
Article
PubMed
CAS
Google Scholar
Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002;97(1):1–4.
Article
PubMed
CAS
Google Scholar
D’Souza RF, Feakins R, Mears L, Sabin CA, Foster GR. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2005;21(5):519–24.
Article
PubMed
CAS
Google Scholar
Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica. 2007;92(8):1037–42.
Article
PubMed
CAS
Google Scholar
Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med. 1994;236(3):315–22.
Article
PubMed
CAS
Google Scholar
Bugianesi E, Manzini P, D’Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 2004;39(1):179–87.
Article
PubMed
CAS
Google Scholar
Ganz T. Systemic iron homeostasis. Physiol Rev. 2013;93(4):1721–41.
Article
PubMed
CAS
Google Scholar
Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta. 2011;412(15–16):1297–305.
Article
PubMed
CAS
Google Scholar
Galicia-Moreno M, Gutierrez-Reyes G. The role of oxidative stress in the development of alcoholic liver disease. Rev Gastroenterol Mex. 2014;79(2):135–44.
PubMed
CAS
Google Scholar
Pemberton PW, Aboutwerat A, Smith A, Burrows PC, McMahon RF, Warnes TW. Oxidant stress in type I autoimmune hepatitis: the link between necroinflammation and fibrogenesis? Biochim Biophys Acta. 2004;1689(3):182–9.
Article
PubMed
CAS
Google Scholar
Choi J, Ou JH. Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G847–51.
Article
PubMed
CAS
Google Scholar
Czaja AJ. Nature and implications of oxidative and nitrosative stresses in autoimmune hepatitis. Dig Dis Sci. 2016;61(10):2784–803.
Article
PubMed
CAS
Google Scholar
Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis. 2005;40(6):834–41.
Article
PubMed
CAS
Google Scholar
Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90(12):4979–86.
Article
PubMed
CAS
Google Scholar
Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010;1800(8):760–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Afify SM, Tabll A, Nawara HM, El KM, Elfert A, Seno M, El-Kousy S. Five fibrosis biomarkers together with serum ferritin level to diagnose liver fibrosis and cirrhosis. Clin Lab. 2018;64(10):1685–93.
PubMed
Google Scholar
Costa-Matos L, Batista P, Monteiro N, Simoes M, Egas C, Pereira J, Pinho H, Santos N, Ribeiro J, Cipriano MA, et al. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Eur J Gastroenterol Hepatol. 2012;24(10):1158–65.
Article
PubMed
CAS
Google Scholar
Martin-Gonzalez C, Pelazas-Gonzalez R, Fernandez-Rodriguez C, Aleman-Valls R, Martinez-Riera A, Ortega-Toledo P, Garcia-Rodriguez A, Rodriguez-Gaspar M, Gonzalez-Reimers E. Ferritin and liver fibrosis among patients with chronic hepatitis C virus infection. J Trace Elem Med Biol. 2020;61:126542.
Article
PubMed
CAS
Google Scholar
Puustinen L, Boyd S, Mustonen H, Arkkila P, Arola J, Farkkila M. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis. Scand J Gastroenterol. 2017;52(3):321–7.
Article
PubMed
CAS
Google Scholar
Liu L, Cao J, Zhong Z, Guo Z, Jiang Y, Bai Y, Xu J. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients. J Clin Lab Anal. 2019;33(7):e22922.
Article
PubMed
PubMed Central
CAS
Google Scholar
Yuan X, Duan SZ, Cao J, Gao N, Xu J, Zhang L. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. Eur J Gastroenterol Hepatol. 2019;31(11):1467–74.
Article
PubMed
PubMed Central
CAS
Google Scholar